NO179196C - Fremgangsmåte for fremstilling av stabile, parenterale opplösninger av 2-fenyl-1,2-benzisoselenazol-3(H)-on - Google Patents

Fremgangsmåte for fremstilling av stabile, parenterale opplösninger av 2-fenyl-1,2-benzisoselenazol-3(H)-on

Info

Publication number
NO179196C
NO179196C NO894281A NO894281A NO179196C NO 179196 C NO179196 C NO 179196C NO 894281 A NO894281 A NO 894281A NO 894281 A NO894281 A NO 894281A NO 179196 C NO179196 C NO 179196C
Authority
NO
Norway
Prior art keywords
benzisoselenazol
phenyl
preparation
parenteral solutions
stable parenteral
Prior art date
Application number
NO894281A
Other languages
English (en)
Norwegian (no)
Other versions
NO179196B (no
NO894281D0 (no
NO894281L (no
Inventor
Jorg Hager
Andrea Michaela Huther
Joachim Roding
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of NO894281D0 publication Critical patent/NO894281D0/no
Publication of NO894281L publication Critical patent/NO894281L/no
Publication of NO179196B publication Critical patent/NO179196B/no
Publication of NO179196C publication Critical patent/NO179196C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
NO894281A 1988-10-29 1989-10-26 Fremgangsmåte for fremstilling av stabile, parenterale opplösninger av 2-fenyl-1,2-benzisoselenazol-3(H)-on NO179196C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3836892A DE3836892A1 (de) 1988-10-29 1988-10-29 Parenteral applizierbare, stabile arzneimittelloesungen

Publications (4)

Publication Number Publication Date
NO894281D0 NO894281D0 (no) 1989-10-26
NO894281L NO894281L (no) 1990-04-30
NO179196B NO179196B (no) 1996-05-20
NO179196C true NO179196C (no) 1996-08-28

Family

ID=6366157

Family Applications (1)

Application Number Title Priority Date Filing Date
NO894281A NO179196C (no) 1988-10-29 1989-10-26 Fremgangsmåte for fremstilling av stabile, parenterale opplösninger av 2-fenyl-1,2-benzisoselenazol-3(H)-on

Country Status (12)

Country Link
EP (1) EP0366990B1 (de)
JP (1) JPH0832629B2 (de)
AT (1) ATE82848T1 (de)
CA (1) CA2001325C (de)
DE (2) DE3836892A1 (de)
DK (1) DK173610B1 (de)
ES (1) ES2052859T3 (de)
FI (1) FI94835C (de)
GR (1) GR3006865T3 (de)
IE (1) IE63152B1 (de)
NO (1) NO179196C (de)
PT (1) PT92142B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4201527A1 (de) * 1992-01-21 1993-07-22 Knoll Ag Lecithinhaltige loesungen mit levemopamil
US5720973A (en) * 1993-02-18 1998-02-24 Knoll Aktiengesellschaft Preparation of colloidal aqueous solutions of active substances of low solubility and a lipid therefor
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
AU3457300A (en) 1999-03-31 2000-10-16 Daiichi Pharmaceutical Co., Ltd. Substrates for thioredoxin reductase
CA2432136A1 (en) * 2000-12-28 2002-07-11 Kiyoshi Ebihara Pharmaceutical emulsion preparation
PL1888033T3 (pl) * 2005-06-09 2014-09-30 Meda Ab Sposób i kompozycja do leczenia chorób zapalnych
PL1919450T3 (pl) * 2005-09-01 2014-11-28 Meda Ab Kompozycja liposomowa zawierająca lek przeciwhistaminowy i kortykosteroid oraz jej zastosowanie do wytwarzania leku do leczenia nieżytu nosa i chorób spokrewnionych
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
EP0165534B1 (de) * 1984-06-22 1989-03-15 A. Nattermann & Cie. GmbH S-(Carbamoyl-phenylselenyl)-Derivate des Glutathions und von Aminomercaptocarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
NO179196B (no) 1996-05-20
DK537889A (da) 1990-04-30
EP0366990A3 (en) 1990-12-19
EP0366990B1 (de) 1992-12-02
FI895112A0 (fi) 1989-10-27
DK537889D0 (da) 1989-10-27
NO894281D0 (no) 1989-10-26
NO894281L (no) 1990-04-30
DE68903736T2 (de) 1993-04-08
ATE82848T1 (de) 1992-12-15
EP0366990A2 (de) 1990-05-09
CA2001325A1 (en) 1990-04-29
DE68903736D1 (de) 1993-01-14
JPH0832629B2 (ja) 1996-03-29
GR3006865T3 (de) 1993-06-30
FI94835C (fi) 1995-11-10
FI94835B (fi) 1995-07-31
DE3836892A1 (de) 1990-05-03
IE893492L (en) 1990-04-29
IE63152B1 (en) 1995-03-22
PT92142B (pt) 1995-06-30
JPH02250876A (ja) 1990-10-08
ES2052859T3 (es) 1994-07-16
CA2001325C (en) 1999-12-21
PT92142A (pt) 1990-04-30
DK173610B1 (da) 2001-04-30

Similar Documents

Publication Publication Date Title
PT81839B (pt) Processo de preparacao de formulacoes com propulsores de aerosol a base de clorofluorocarbono contendo medicamento
DK549189A (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
DK319481A (da) Fremgangsmaade til fremstilling af forbindelse indeholdende 2-phenyl-1,2-benzioselenazol-3(2h)-on
ES2065906T3 (es) Produccion de proteinas en formas activas.
FI88256B (fi) Foerfarande foer framstaellning av fasta laekemedelspreparat av 2-fenyl-1,2-bensisoselenazol-3(2h)-on (ebselen)
ATE82857T1 (de) Interleukin-2-zusammensetzungen.
NO179196C (no) Fremgangsmåte for fremstilling av stabile, parenterale opplösninger av 2-fenyl-1,2-benzisoselenazol-3(H)-on
DK0826370T3 (da) Lægemiddel indeholdende 2-phenyl-1, 2-benzisoselenazol-3(2H)-on til behandling af Alzheimers sygdom
DK278788A (da) Ostomikobling
DE69130292D1 (de) Verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
NO911634D0 (no) Fremgangsmaate for fremstilling av konturstabile gjenstander.
DE69106008D1 (de) Behandlung von Schlaf-Apnoea mit Azapironderivaten.
KR900009591A (ko) 피리딘-3-퍼옥시카르복실산 모노퍼술페이트
SE8802323L (sv) 8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma
ES8404358A1 (es) Un procedimiento para obtener derivados de isoxazolopirimidina.
DE3483318D1 (de) Lorazepam-haltiges schlafmittel.
FI901459A0 (fi) In vitro-syntes av ingripande rna.
Kingston Socialist feminism: Necessary but insufficient: Comment on" Feminism and family therapy: A possible meeting point," by J. Pilias and J. Anderton.
IT8847797A0 (it) Derivati dell' 1.3 -diossalano e dell'1.3-diossano e loro impiegocome medicamenti